je.st
news
Reasons to Expect Strong Bristol-Myers Earnings
2016-01-26 03:13:49| Biotech - Topix.net
Recent market volatility and global pressures have tempered investors' expectations for a strong earnings season, but not all companies will do poorly. Although Bristol-Myers Squibb shares -- down some 7% year to date -- is not off to a good start in 2016, the multinational drug giant belongs on any short list of companies poised to beat Wall Street's earnings estimates.
Tags: strong
reasons
expect
earnings
Category:Biotechnology and Pharmaceuticals